EXPERIMENTAL AND CLINICAL PHARMACOLOGY OF RIFAXIMIN SELECTIVE ENTERIC ANTIBIOTIC
Solvay pharma expands its product portfolio, by launching alfa normix (rifaximin) for the treatment of the gastroenteric infections. Alfa normix is a non-systemic broad-spectrum antibiotic to treat acute gastroenteric infections and is prescribed for the travelers suffering from diarrhea, the overgr...
Na minha lista:
Autor principal: | article editorial (Autor) |
---|---|
Formato: | Livro |
Publicado em: |
Union of pediatricians of Russia,
2008-05-01T00:00:00Z.
|
Assuntos: | |
Acesso em linha: | Connect to this object online. |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
Registros relacionados
-
EXPERIMENTAL AND CLINICAL PHARMACOLOGY OF RIFAXIMIN SELECTIVE ENTERIC ANTIBIOTIC
por: article editorial
Publicado em: (2008) -
RIFAXIMIN TO TREAT OF GASTROINTESTINAL INFECTIONS
por: article editorial
Publicado em: (2008) -
RIFAXIMIN TO TREAT OF GASTROINTESTINAL INFECTIONS
por: article editorial
Publicado em: (2008) -
Use of Rifaximin in Irritable Bowel Syndrome Treatment
por: Hubert Wróblewski, et al.
Publicado em: (2021) -
Diverticular Disease and Rifaximin: An Evidence-Based Review
por: Anna Piccin, et al.
Publicado em: (2023)